ArticleEuropean journal of pain (London, England)2026
Alpha Oscillations and Conditioned Pain Modulation Is Associated With Treatment Resistance to Spinal Cord Stimulation for Neuropathic Pain.
Article in European journal of pain (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundNeuropathic pain (NP) is a severe form of chronic pain associated with reduced quality of life. Spinal cord stimulation (SCS) can provide pain relief for some but not all treated, highlighting the importance of predictive markers. Previous studies have found that individuals with NP have abnormal alpha oscillations detected by resting state magnetoencephalography (MEG) and altered conditioned pain modulation (CPM). In the current study, we tested whether these measures predicted SCS outcome.
methodsForty patients with NP (22F, 18 M) were evaluated before a 12-day trial of SCS including pain self-reports, CPM, magnetic resonance imaging (MRI) and 5-min MEG scans to evaluate alpha oscillations (8-13 Hz) in the dynamic pain connectome. Those with ≥ 30% pain reduction post-trial were considered treatment responders. Twenty-nine age- and sex-matched healthy controls (HC) (17F, 12 M) also underwent CPM testing and MEG.
resultsHalf of the patients treated were classified as responders based on reduced pain intensity. Responders also had significantly improved quality of life compared to nonresponders. There were 2 key findings from the pre-SCS testing: (1) Pain relief following SCS significantly correlated with lower alpha power in nodes of the salience network and ascending nociceptive pathway; this relationship demonstrated regionally specific sex trends; and (2) Nonresponders exhibited significantly abnormal inefficient CPM (whole spectrum or inhibitory) and reduced peak alpha frequency in the subgenual anterior cingulate cortex, which had a strong effect size.
conclusionsAbnormal brain-behaviour features involving alpha oscillations and CPM may underlie the ineffectiveness of SCS to treat NP. SIGNIFICANCE STATEMENT: These findings not only build on our fundamental understanding of the individual variability and abnormalities in brain-behavioural measures in NP but also demonstrate their potential predictive value when considering personalised pain management with SCS treatment and potential neural targets for those resistant to SCS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.